Labcorp Holdings Inc. (LH) Stock Analysis & Investment Frameworks
Labcorp Holdings Inc. (LH) stock analysis on Invetso. Review Labcorp Holdings Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Labcorp Holdings Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
Labcorp Holdings Inc. Key Financial Metrics
- Market Cap: $26.21B
- Revenue: $13.95B
- P/E Ratio: 29.89
- ROE: 11.57%
- ROIC: 7.93%
- Dividend Yield: 0.89%
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
Labcorp Holdings Inc. Investment Frameworks
Invetso analyzes Labcorp Holdings Inc. (LH) across the following frameworks:
- Labcorp Holdings Inc. 10Y Growth Potential
- Labcorp Holdings Inc. Scenario Analysis
- Labcorp Holdings Inc. Risks & Opportunities
- Labcorp Holdings Inc. Economic Moat
- Labcorp Holdings Inc. Business Model
- Labcorp Holdings Inc. Management
- Labcorp Holdings Inc. SWOT Analysis
- Labcorp Holdings Inc. Porter's 5 Forces
- Labcorp Holdings Inc. PESTLE Analysis
- Labcorp Holdings Inc. ESG Analysis